Dapagliflozin: Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes

PDD00017273 : Targeting OGG1 and PARG radiosensitises head and neck cancer cells to high-LET protons through complex DNA damage persistence